Renaissance Technologies
EVAR

Renaissance Technologies’s Lombard Medical, Inc. EVAR Stock Holding History

Renaissance Technologies’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-27,734
Closed -$22K – 3488
2017
Q1 		$22K Buy
+27,734
New +$18.1K ﹤0.01% 3174

Other funds holding EVAR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Renaissance Technologies's EVAR Position: Q2 2017 in Review

Renaissance Technologies sold out of Lombard Medical, Inc. (EVAR) in Q2 2017, closing a stake of 27,734 shares — an estimated $22K sold.

Renaissance Technologies first reported a position in EVAR in Q1 2017 and held it in 1 quarter. The position peaked at $22K in Q1 2017. 12 funds tracked by Wall St. Rank hold EVAR as of Q2 2017.

  • Renaissance Technologies reported no remaining Lombard Medical, Inc. position as of Q2 2017 after selling out during the quarter.
  • Renaissance Technologies sold 27,734 Lombard Medical, Inc. shares in Q2 2017, an estimated $22K.
  • Renaissance Technologies first reported a position in Lombard Medical, Inc. in Q1 2017 and held it in 1 quarter.
  • Renaissance Technologies's Lombard Medical, Inc. position peaked at $22K in Q1 2017.
  • 12 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q2 2017.

Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.